Genetic variants predict lithium response in bipolar disorder – first step in identifying effectiveness of lithium https://t.co/qanIp7Jn8m — Schizophrenia SFNSW (@SFNSW) February 8, 2016 Genetic variations on a stretch of chromosome may predict responsiveness among patients with bipolar disorder to the mood stabilizing drug lithium (multiple brands), a genome-wide analysis
http://psychcentral.com/news/2015/10/24/the-effectiveness-of-talk-therapies-for-bipolar-disorder/93903.html Lithium, the first drug treatment used for bipolar disorder, was considered so effective when it was introduced that medication has been the primary focus of bipolar treatment ever since. Relatively little attention has been paid to psychosocial treatments for bipolar disorder, a condition characterized by alternating depression and mania.
What is bipolar disorder? Bipolar disorder is the name used to describe a set of ‘mood swing‘ conditions, the most severe form of which used to be called ‘manic depression‘. Bipolar disorder I is the more severe disorder in terms of symptoms- with individuals being more likely to experience mania,
http://www.blackdoginstitute.org.au/public/bipolardisorder/self-test.cfm Only if you answer ‘yes’ to the first three questions should you continue on with the checklist. Question 1: Have you had episodes of clinical depression – involving a period of at least 2 weeks where you were significantly depressed and unable to work or only able to work